Selective Internal Radiation Therapy for Gastrointestinal Neuroendocrine Tumour Liver Metastases: A New and Effective Modality for Treatment

Table 1

Patient details and response to selective internal radiation therapy.

Patient	Gender	Age	Carcinoid syndrome	Liver Involvement	5HIAA response	CT response	Survival (months)
1*	Male	29	Yes	25–50%	Yes	Yes	34.2^†
2	Female	49	Yes	>50%	n/a	Yes	26.9^†
3	Male	70	No	>50%	n/a	Yes	11.9^†
4	Male	64	Yes	<25%	Yes	Yes	110^†
5*	Male	71	Yes	<25%	Yes	Yes	37^†
6*	Female	46	Yes	>50%	Yes	Yes	79^†
7*	Female	60	No	<25%	n/a	Yes	60
8	Male	52	No	<25%	n/a	Yes	58
9	Male	61	Yes	50%	n/a	Yes	16.4^†
10*	Female	60	Yes	25–50%	No	Yes	21^†
11*	Male	72	Yes	<25%	Yes	Yes	23
12*	Male	60	No	<25%	Yes	Yes	23
13*	Male	56	Yes	<25%	n/a	Yes	22
14	Female	73	Yes	<25%	n/a	Yes	19

^†Deceased; *received hepatic artery chemotherapy.